MedTrace Logo

Acetazolamide for the Prevention of Post Operative CSF Leak

NCT04351061 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2021-12-14

No results posted yet for this study

Summary

The purpose of this research is to test the use of Acetazolamide in preventing post-operative cerebrospinal fluid leak in patients having endoscopic skull base surgery (it is a surgery performed through the nose and sinus).

Conditions

  • Cerebrospinal Fluid Leak

Interventions

DRUG

Acetazolamide

Acetazolamide 500 mg by mouth twice per day for 7 consecutive days.

Sponsors & Collaborators

  • University of Miami

    lead OTHER

Principal Investigators

  • Ronald Benveniste, MD, PhD · University of Miami

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-07
Primary Completion
2021-11-24
Completion
2021-11-24
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04351061 on ClinicalTrials.gov